Clin2
NCT06241274Possibly a fitRecruiting

Moxibustion for bladder bleeding after stem cell transplant

MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic CystitisTreatment

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether moxibustion (a traditional heat therapy) can help manage bladder bleeding that occurs after a donor stem cell transplant. If you have this condition, the trial aims to see if this gentle treatment can reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You have bladder bleeding (hemorrhagic cystitis) after an allogeneic stem cell transplant.
  • You have no broken or very sensitive skin where moxibustion would be done.
  • You did not receive a reduced-intensity conditioning regimen before your transplant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06599346Recruiting
MSC supernatant for skin and mouth sores in blood cancer patients

This trial tests whether a liquid made from stem cells (MSC supernatant) can help prevent or treat mouth, skin, and bladder sores that often happen after stem cell transplants, chemotherapy, or radiation therapy.

Chengdu, Sichuan
NCT07638332Not yet recruiting· Phase 1/Phase 2
BK Virus Bladder Infection Treatment After Stem Cell Transplant

This trial tests a new cell therapy (LB-DTK-BKV) for patients who developed a painful BK virus bladder infection after receiving a stem cell transplant and didn't improve with standard treatment. The therapy may help control the virus and reduce bleeding and pain.

Seoul, Seoul
NCT07442513Recruiting· Phase 3
Preventing Bleeding in Stem Cell Transplant

This trial tests if a medication called etamsylate can help prevent bleeding in patients getting a stem cell transplant. If your platelet count drops very low after transplant, this drug may reduce your risk of bleeding.

Hangzhou, Zhejiang
NCT07572669Recruiting· Phase 2
Moxibustion for Steroid-Resistant Graft-Versus-Host Disease

This trial tests whether moxibustion—a traditional Chinese medicine technique using heat from burning mugwort—can help treat acute graft-versus-host disease (a complication after bone marrow transplant) that hasn't responded to steroid drugs. If you've had a stem cell transplant and developed this condition that won't go away with standard treatment, this study may be for you.

Wuhan, Hubei
NCT07665619Not yet recruiting· Early Phase 1
Stem cell therapy for radiation cystitis

This study tests a new treatment for radiation cystitis, a bladder condition caused by past pelvic radiation. It combines stem-cell derived particles with a standard bladder instillation to see if it helps improve symptoms like urgency or blood in urine.

NCT06218927Recruiting
Stem cell transplant and bladder function in MS

This study looks at whether a stem cell transplant (AHSCT) can improve bladder problems and quality of life in people with multiple sclerosis (MS). It compares people getting this treatment with those on standard MS therapy.

Ostrava, Moravian-Silesian Region

Hear when a new Moxibustion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.